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Abstract
Background: The Wnt signaling pathway is a cellular communication pathway that plays critical
roles in development and disease. A major class of Wnt signaling regulators is the Dickkopf (Dkk)
family of secreted glycoproteins. Although the biological properties of Dickkopf 1 (Dkk1) and
Dickkopf 2 (Dkk2) are well characterized, little is known about the function of the related Dickkopf
3 (Dkk3) protein in vivo or in cell lines. We recently demonstrated that Dkk3 transcripts are
upregulated during photoreceptor death in a mouse model of retinal degeneration. In this study,
we characterized the activity of Dkk3 in Wnt signaling and cell death.
Results: Dkk3 was localized to Müller glia and retinal ganglion cells in developing and adult mouse
retina. Western blotting confirmed that Dkk3 is secreted from Müller glia cells in culture. We
demonstrated that Dkk3 potentiated Wnt signaling in Müller glia and HEK293 cells but not in COS7
cells, indicating that it is a cell-type specific regulator of Wnt signaling. This unique Dkk3 activity
was blocked by co-expression of Dkk1. Additionally, Dkk3 displayed pro-survival properties by
decreasing caspase activation and increasing viability in HEK293 cells exposed to staurosporine and
H2O2. In contrast, Dkk3 did not protect COS7 cells from apoptosis.
Conclusion: These data demonstrate that Dkk3 is a positive regulator of Wnt signaling, in
contrast to its family member Dkk1. Furthermore, Dkk3 protects against apoptosis by reducing
caspase activity, suggesting that Dkk3 may play a cytoprotective role in the retina.
Background
Wnt ligands are secreted glycoproteins that control a wide
range of processes in the developing embryo and in adult
tissues. Aberrant Wnt signaling is increasingly being
implicated in numerous diseases, including malignancies,
Alzheimers disease, retinal degenerations and abnormal
development of the eye, limbs and skeleton [1-3]. Charac-
terizing proteins that regulate the Wnt pathway have
revealed important insights into Wnt-dependent proc-
esses and potential directions towards novel therapies [4].
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The best understood of the major Wnt pathways is the
canonical/β-catenin pathway. In the absence of Wnt lig-
ands, β-catenin levels are suppressed by the APC-axin-
GSK3β protein complex via phosphorylation and subse-
quent degradation by the proteosome [5]. β-catenin is a
transcriptional cofactor and is also an essential compo-
nent of cell-cell adhesion complexes. Wnt ligands bind to
the cell surface receptors Frizzled and LDL receptor related
proteins 5 and 6 (LRP5/6), leading to Disheveled activa-
tion and ultimately reducing β-catenin degradation. Stabi-
lized β-catenin is transported into the nucleus where it
binds to Tcf/Lef type transcription factors and initiates
transcription of Wnt target genes.
The Dickkopf (Dkk) family of proteins, Dkk1, 2, 3 and 4
and Soggy, are secreted regulators of Wnt signaling [6-8].
The five Dkk proteins share 37–50% protein identity and
contain two conserved cysteine-rich regions separated by
a variable linker region [8]. Dkk1, Dkk2 and Dkk4 inhibit
Wnt signaling by binding to LRP5/6 and the transmem-
brane protein Kremen which results in LRP5/6 internali-
zation and prevents Wnt and Frizzled from forming an
active complex with LRP5/6 [9,10]. Dkk2 can also activate
the Wnt pathway in certain situations, depending on the
cell type, the presence of Wnt ligands and levels of LRP5/
6 [11-13].
Unlike its related family members, characterizing Dkk3
activity has been elusive. Dkk3 did not regulate Wnt sign-
aling in various activity assays, including Wnt-dependent
secondary axis induction in Xenopus embryos and Wnt1/
Fz8 signaling in cultured cells [8,11,12]. Dkk3 also did
not physicallyinteract with LRP5/6 or Kremen [9,14].
However, Caricasole et al demonstrated that Dkk3 was a
weak inhibitor of Wnt7A signaling in PC12 cells although
co-expression of LRP5 or LRP6 was required to uncover
this activity [15]. Dkk3 displayed Wnt inhibitor activity in
the osteocarcinoma Saos-2 cell line, measured by
decreased cytoplasmic levels of β-catenin [16], but did not
inhibit Wnt reporter Tcf/Lef luciferase activity assays in a
prostate cancer cell line [17]. Therefore, the relationship
between Dkk3 and Wnt signaling is unclear despite its
sequence similarity to the other Dkk genes.
Dkk3 is expressed during embryonic development in
many organs, including neural epithelium, limb bud,
bone and heart, particularly in regions of epithelial-mes-
enchyme transformation [18]. Dkk3 is also widely
expressed in adult tissues, with the highest levels found in
the heart and brain [8]. Dkk3-deficient mice develop nor-
mally, are fertile and have a mild phenotype that includes
hyperactivity, increased immunological and hematologi-
cal markers and a slight decrease in lung ventilation [19].
The absence of severe phenotypes in Dkk3 knock-out
mice may be due to compensation from the Dkk3
homolog soggy [19]. Alternatively, physiological stress or
injury may be required for the appearance of a Dkk3-
dependent phenotype.
In this study, we investigated the activity of Dkk3 in Wnt
signaling and cell death. We demonstrated two novel
functions for Dkk3. First, Dkk3 is a cell-specific positive
regulator of the canonical Wnt signaling pathway in pri-
mary cell culture and cell lines. Second, Dkk3 protected
transfected cells from apoptotic stress. We also character-
ized the distribution of Dkk3 in the retina and found that
Dkk3 is expressed highly in Müller glia and ganglion cells
during retinal development and in adult retina. Müller
glia are the principle supportive glia in the retina and are
believed to protect photoreceptors during retinal injury by
secreting growth factors [20-23]. We previously demon-
strated that Dkk3 transcripts were increased in a mouse
model of retinal degeneration, particularly during cone
photoreceptor death [24]. Furthermore, Wnt signaling is
upregulated during retinal degeneration in Müller glia
and Wnt activators protect primary photoreceptor cultures
from apoptosis [25]. Together, these results identify for
the first time that Dkk3 is a secreted pro-survival signaling
protein, and suggest that Dkk3 may play a role in Müller
glia activity in the retina.
Results
Dkk3 is expressed and secreted from retinal Müller glia
Cellular differentiation in the mouse retina into the major
neuronal and glial cell types occurs at stereotypic time-
points during the neo-natal period. We used immunohis-
tochemistry to characterize the distribution of Dkk3 dur-
ing post-natal retinal development, especially during the
time of Müller glia differentiation. Dkk3 immunoreactiv-
ity is present diffusely at post-natal day (P) 5 and becomes
concentrated in the developing synaptic layers in the outer
plexiform layer (OPL) and ganglion cell layer (GCL) by
P8, and then remains in these locations through the
beginning of Müller glia differentiation (P10-12) (Figure
1). As Müller glia cells continue to differentiate during
P12 to P20, Dkk3 becomes more concentrated in the
inner nuclear layer (INL), where nuclei of the interneu-
rons horizontal cells, bipolar cells and amacrine cells are
located, and in the narrow margin composed of the pho-
toreceptor inner segments and the external limiting mem-
brane. Localization to this inner segment region (IS)
suggests that Dkk3 is expressed in or secreted from Müller
glia end-feet. By P20, Dkk3 appears associated with radial
fibers extending across the retina, which correspond to
Müller glia processes.
Dkk3 remained localized in the inner nuclear layer and
the ganglion cell layer in adult mouse retina (Figure
2B–E), consistent with our previous study localizing Dkk3
transcript distribution [24]. Dkk3 staining in the adultBMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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also remained prominent in the synaptic plexiform layers
between the ONL and INL, and the INL and GCL, and the
photoreceptor inner segment (IS) region. Double immu-
nostaining using antibodies against Dkk3 and the Müller
glia marker glutamine synthetase (GS) indicate that Dkk3
colocalizes with GS-positive Müller glia radial fibers and
cell bodies (Figure 2C,E, arrows). The immunostaining in
Figures 1 and 2 used different anti-Dkk3 antibodies (see
Methods) and the equivalent staining patterns confirm
the specificity of Dkk3 detection. The specificity of the
antibody was confirmed by Western blotting, which
detected a single band at the predicted size (Figure 2A,K).
Müller glia span the entire thickness of the tissue,
ensheathing and interacting with all retinal neurons.
Müller glia are vital to the normal retinal function by reg-
ulating ion concentrations, signaling molecules and neu-
rotransmitters, mediating water transport, and removing
glutamate and scavenging free radicals. During retinal
degeneration Müller glia are believed to secrete pro-sur-
vival growth factors that protect remaining photorecep-
tors from injury. To confirm Dkk3 expression in glia we
cultured Müller glia from rat and mouse retinas. One hun-
dred percent of the Müller glia showed colocalization of
Dkk3 with the Müller glia marker protein glutamine syn-
Dkk3 protein is expressed in the retina during Müller glial cell differentiation Figure 1
Dkk3 protein is expressed in the retina during Müller glial cell differentiation. Dkk3 immunoreactivity is present diffusely in 
the developing retina at P5 and at P8 it is localized to the outer plexiform layer (OPL), the site of synaptic processes between photore-
ceptors and interneurons, and the ganglion cell layer (GCL), where it remains at P10 and P12. During the later stages of retinal differenti-
ation Dkk3 becomes predominantly localized to the inner nuclear layer (INL) and at the inner segment region (IS, arrow), consistent with 
localization to Müller glia cell bodies and end-feet. Expression in the OPL and GCL remains high at these ages. By P20, Dkk3 appears 
localized along radial fibers, representing Müller glia processes, extending across the retina. These fibers are particularly visible in the 
outer nuclear layer (ONL). IPL, inner plexiform layer.BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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thetase (Figure 2F–I). Dkk3 was distributed along proc-
esses and also in a punctate peri-nuclear pattern,
consistent with the endoplasmic reticulum/Golgi com-
plex. This peri-nuclear localization is evident in a higher
magnification image of the human Müller glia cell line
MIO-M1 [26] (Figure 2J). Western blotting confirmed that
Dkk3 is secreted (M, media) from MIO-M1 cultures (Fig-
ure 2K).
Dkk3 regulates Wnt signaling
Wnt signaling was measured using a transcriptional
reporter assay with the TOP-FLASH luciferase plasmid.
MIO-M1 Müller glia cells were cotransfected with TOP-
FLASH and LacZ plasmids along with Dkk1, Dkk3 or a
control gene (GFP). At 48 hrs post-transfection, the trans-
fected cells were incubated with Wnt3a-containing condi-
tioned media or control conditioned media that lacks the
Wnt3a ligand.
Dkk3 is expressed in adult mouse retina, primary Müller glia culture and a human Müller glial cell line Figure 2
Dkk3 is expressed in adult mouse retina, primary Müller glia culture and a human Müller glial cell line. (A) Western blot 
on lysates from retina, HEK293 cells and a stable cell line expressing Dkk3 (HEK-Dkk3). A single band at 58 kDa, representing post-trans-
lationally modified Dkk3, is observed in the retina and in the Dkk3 stable cell line. Smaller bands likely represent degradation products or 
partially glycosylated Dkk3. (B-E) Dkk3 (green) is located in the photoreceptor inner segment region (IS), inner nuclear layer (INL) and 
ganglion cell layer (GCL) of adult wild type mice. There is also strong staining in the inner plexiform layer between the INL and GCL. The 
Müller glia marker glutamine synthetase (GS) is red and DAPI-stained nuclei are blue. The outer nuclear layer (ONL) contains the pho-
toreceptor nuclei. Dkk3 colocalizes with GS-positive Müller glia radial fibers and cell bodies (Figure 2E,C arrows). (F-I) Confirmation of 
Dkk3 localization in Müller glia. Rat primary Müller glia were isolated from the retina and cultured. Dkk3 (green) is found in the same cells 
as the Müller glia marker glutamine synthetase (red). DAPI-stained nuclei are blue and the merged image is shown. (G) Dkk3 (green) is 
expressed in the perinuclear region and along processes in the human Müller glial cell line MIO-M1. Scale bar in B and F is 20 μm and in J 
is 100 μm. (H) Dkk3 is secreted from MIO-M1 cells. Precipitated proteins from the culture media were separated on a Western blot. 
The 58 kDa glycosylated Dkk3 is present in both cell lysate (L) and media (M) whereas the 38 kDa non-glycosylated form is not secreted 
and is only in the cell lysate fraction. β-actin was used as a control.BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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Wnt signaling was induced by Wnt3a conditioned media
in the MIO-M1 human Müller glia cell line (Figure 3A),
indicating that these cells are Wnt-responsive, as we
recently demonstrated [25]. The mutated control reporter
FOP-FLASH did not show a response to Wnt3a, as
expected (Figure 3A). Dkk1 reduced Wnt3a-induced sign-
aling in MIO-M1 cells by approximately five-fold (Figure
3B) compared with GFP expression. In contrast, Dkk3
induced approximately two-fold higher Wnt signaling
compared with GFP (Figure 3B). Interestingly, Dkk3
potentiating activity was cell-type specific. In contrast to
the MIO-M1 cells, Dkk3 had a small inhibitory, although
not significant, effect on Wnt3a-induced signaling in the
COS7 cell line and reduced luciferase activity by 33%com-
pared with control tr ansfections (Figure 3B). Dkk1
decreased luciferase activity by 67% in COS7 cells (Figure
3B). This result suggests that COS7 cells do not have the
molecular mechanisms to convey Dkk3 potentiating
activity or that the inhibitor activity of Dkk3 is greater
than, and over-rides, its potentiating activity.
Dkk3 increased Wnt3a-induced signaling in primary
Müller glia isolated from mouse retina. In these experi-
ments we tested the activity of Dkk3 when it was added to
the glia cells as conditioned media. HEK293 cells stably
expressing Dkk3 were created and used as a source of
Dkk3 [2] (see Methods). Dkk3 treatment in the absence of
Wnt3a produced baseline levels of Wnt signaling and was
equivalent to control media not containing Dkk3 (Figure
3C). Dkk3 by itself had baseline levels in all the cell types
tested, indicating that Dkk3 potentiates the Wnt pathway
when it is stimulated by Wnt3a but cannot initiate signal-
ing on its own.
Incubating primary Müller glia in Dkk3-containing condi-
tioned media increased Wnt signaling by 1.8-fold
(Dkk3+Wnt3a compared with Wnt3a treatment alone
(control+Wnt3a)). (Figure 3C). Although co-stimulation
with a Wnt ligand was required to demonstrate Dkk3
activity, over-expression of Wnt receptors was not neces-
sary, in contrast to Dkk3 activity in PC12 cells [15].
To begin to explore the mechanism of Wnt regulation by
Dkk3, we tested whether Dkk1 blocks Dkk3 activity. For
this experiment we used a Dkk3 stable cell line made in
HEK293 cells to ensure that the majority of cells coex-
pressed Dkk3 and Dkk1. We previously demonstrated
that Dkk3 potentiated Wnt signaling in this cell type[2].
Wnt3a ligand induced significantly more Wnt signaling in
the cells expressing Dkk3 than the control cell line made
with the empty vector (Figure 4, compare white and black
bars in cells without Dkk1). If Dkk3 acts independently
from Dkk1 then we expect that Dkk1 would not fully
inhibit Wnt signaling in Dkk3-expressing cells compared
with the vector cell line, and that the combination of
Dkk3 + Dkk1 + Wnt3a would be less inhibited and have
more Wnt signaling than Dkk1 + Wnt3a in the vector cell
line. As shown in Figure 4, Dkk1 inhibited Wnt3a-
induced signaling to an equivalent extent in the Dkk3 and
vector stable cell lines. This result suggests that Dkk3-
Dkk3 is a positive regulator of Wnt signaling in Müller glia  and a negative regulator in COS7 cells Figure 3
Dkk3 is a positive regulator of Wnt signaling in Müller glia 
and a negative regulator in COS7 cells. (A) Wnt signaling 
was induced by Wnt3a conditioned media in the MIO-M1 human 
Müller glia cell line, measured using the TOP-FLASH Wnt luci-
ferase reporter assay. The mutated control reporter FOP-FLASH 
did not show a response to Wnt3a. Induction is expressed as fold 
change of conditioned media containing Wnt3a to conditioned 
media not containing Wnt3a. (B) Luciferase reporter assays in 
cells transfected with Dkk1, Dkk3 and a control gene (GFP). Dkk3 
increased Wnt3a-induced Wnt signaling whereas Dkk1 decreased 
Wnt signaling in the MIO-M1 human Müller glia cell line (black 
bars). Wnt signaling was measured using the TOP-FLASH luci-
ferase assay. Wnt signaling is shown relative to GFP-expressing 
cells. In the COS7 cell line (grey bars), Dkk1 reduced Wnt signal-
ing and Dkk3 had a small but not significant inhibitory effect. (C) 
Primary Müller glia cultured from the mouse retina that were 
treated with conditioned media with or without Dkk3 had base-
line luciferase levels. Incubation with Wnt3a showed a significant 
induction of Wnt signaling that was greater when Dkk3 was 
present (Dkk3+Wnt3a) than when Wnt3a was added alone with-
out Dkk3 (Control+Wnt3a). * = p < 0.05, *** = p < 0.001, relative 
to GFP-expressing cells. Mean ± standard deviation is shown.BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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mediated potentiation of Wnt3a signaling is dependent
on, or occurs upstream from, a Dkk1-controlled pathway
or receptor.
Finally, it is unlikely that the transfection method influ-
enced the effect of Dkk3 because there is no correlation
between Dkk3 activity and lipofectamine or electropora-
tion. For example, Dkk3 had opposite effects in HEK293
and COS7 cells despite both being transfected with lipo-
fectamine, whereas Dkk3 activity was similar in MIO-M1
cells as HEK293 despite the former being transfected
using electroporation.
Dkk3 regulates cell death
We next investigated whether Dkk3 plays a role in cell sur-
vival by testing the effect of Dkk3 expression on cell death
induced by H2O2 and staurosporine. The HEK293 cell line
was used because it has Dkk3-responsive Wnt signaling
(Figure 4 and [2]), indicating the potential presence of
Dkk3 receptors and signaling proteins. HEK293 cells were
transiently transfected with Dkk3 or the control genes
LacZ or BclXL and were exposed to 0.3 to 0.8 mM H2O2 for
24 hr. Dkk3 expression significantly increased viability in
cells exposed to H2O2, compared with the LacZ transfec-
tion control (Figure 5A). Indeed, the pro-survival effect of
Dkk3 was equivalent to the anti-apoptotic gene BclXL used
as the positive control. The baseline viability of HEK293
cells transfected with Dkk3 and Vector were equivalent in
the absence of apoptotic inducers (data not shown).
Dkk3 transfection also decreased apoptosis induced by
staurosporine, a well-characterized pro-apoptotic protein
kinase inhibitor. Dkk3 expression reduced caspase activa-
tion by 4-fold in HEK293 cells, compared with the vector
Dkk3 regulates cell death Figure 5
Dkk3 regulates cell death. (A) HEK293 cells were transiently 
transfected with LacZ, Dkk3, or BclxL and exposed to H2O2 for 
24 hr. Viability was measured by XTT assay and was normalized to 
0 mM H2O2. Dkk3 expression significantly increased viability in 
the presence of H2O2 compared with LacZ control. There was no 
difference between Dkk3 and BclXL. ** = p < 0.001, comparison 
between Dkk3 and LacZ. The comparison between BclXL and 
LacZ was also significant at p < 0.001 at each concentration of 
H2O2. (B) Dkk3 significantly protected HEK293 cells against apop-
tosis induced by staurosporine. HEK293 cells expressing Dkk3 or 
Vector control were exposed to 1 μM staurosporine (STS) or the 
DMSO vehicle control for 16 hrs. Caspase activity was measured 
and relative fluorescent intensity (RFI) units were normalized to 
micrograms of protein. *** = p < 0.001, comparison between 
Dkk3 cells and Vector cells treated with STS. (C) Dkk3 did not 
protect COS7 cells exposed to staurosporine. Caspase activity 
(RFI/microgram of protein) was compared with cells transfected 
with the pcDNA3 empty vector. Mean ± standard deviation is 
shown.
Dkk1 blocks Dkk3 activity Figure 4
Dkk1 blocks Dkk3 activity. Dkk3 (white bars) and control 
(black bars) stable cell lines (HEK293 cells) were transfected with 
the control vector ("no Dkk1") and TOP-FLASH and LacZ plas-
mids then treated with Wnt3a. The Dkk3 cell line had more Wnt 
signaling than the vector control line (Luciferase Activity units 
shown). Transfection of Dkk1 completely abolished Wnt signaling 
in both the Dkk3 stable cell line and the control cell line. This 
result suggests that Dkk3 acts in a Dkk1-dependent pathway. * = p 
< 0.05. Mean ± standard deviation is shown.BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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control (Figure 5B). Protection from apoptosis was also
observed in three independent clones of HEK293 cell
lines stably expressing Dkk3 (data not shown). However,
Dkk3 did not reduce caspase activity in COS7 cells (Figure
5C). Therefore, Dkk3 demonstrates cell-specific protec-
tion, similar to its cell-specific potentiation of Wnt signal-
ing.
Discussion and Conclusion
The function of Dkk3 and its role in Wnt signaling had
been unclear despite it sharing approximately 40% pro-
tein identity to the well-characterized Dkk1 and Dkk2
Wnt inhibitors. In the present study, we found that Dkk3
is a cell-type specific regulator of Wnt signaling. Dkk3
increased Wnt activation in primary Müller glia cultures, a
Müller glia cell line and in HEK293 cells, but not in COS7
cells. Dkk3 activity was not dependent on the method of
delivery because transient and stable transfections of
Dkk3 plasmids and treatment with Dkk3 conditioned
media demonstrated equivalent results. Although the
effect of Dkk3 on Wnt signaling may be indirect, to our
knowledge this is the first demonstration that Dkk3 acts as
a cell-specific positive regulator of the Wnt pathway.
Dkk3 was originally proposed to be a divergent, non-Wnt
regulating Dkk family member [8] although later studies
indicated that Dkk3 inhibits Wnt signaling in PC12 and
osteocarcinoma Saos-2 cells [15,16]. Discrepant effects on
the Wnt pathway have been observed for other Wnt regu-
lator genes. For example, Dkk2 activates Wnt signaling
when coexpressed with certain Frizzled and LRP6 recep-
tors but inhibits Wnt signaling in other situations [12,13].
Wnt1 also activates canonical Wnt signaling in some cell
lines but inhibits Wnt signaling in others [27]. Further-
more, the non-canonical Wnt/Ca2+  pathway activator
Wnt5a activates canonical Wnt signaling in HEK293 cells
when the co-receptors Fz4 and LRP5 are over-expressed,
but inhibits canonical signaling in the absence of these
receptors [28]. Therefore, Wnt signaling activation in
vitro, and potentially also in vivo, is not a sole property of
the ligand or regulator but appears to be related to other
factors, including receptor availability [28].
Receptor context influences the regulation of canonical
Wnt signaling by Dkk2 [11] and Wnt5a [28], suggesting
that specific receptor components in HEK293 and Müller
glia, such as a putative Dkk3 receptor, may mediate the
Wnt-inducing activity of Dkk3. Absence or lower expres-
sion of these components may cause its inhibitory activity
in COS7 (Figure 4) and PC12 cells [15] and its inactivity
in other assays. Although Dkk3 activity was blocked by
Dkk1 coexpression in HEK293 cells, the mechanism of
Wnt modulation by Dkk3 may differ from Dkk1 and
Dkk2 because Dkk3 does not bind to Kremen or LRP pro-
teins [9,14]. Future studies will investigate the factors that
are required for Dkk3 activity.
We demonstrated that Dkk3 has pro-survival properties in
HEK293 cells but not in COS7 cells. This cellular differ-
ence between Dkk3 protection also suggests that COS7
cells lack the appropriate Dkk3 receptors, although this
cell type does express endogenous Dkk3 (data not
shown). Although the Wnt pathway itself is protective in
most tissues [29,30], Dkk3-mediated cellular protection is
unlikely to be dependent on Wnt signaling because
Wnt3a was not added in the apoptosis assays. However,
we cannot exclude the possibility that low levels of Wnt
activators are present in the culture serum.
Several reports demonstrated that Dkk3 regulates cell
death in cancer cells, protecting osteocarcinoma cells
against serum starvation and chemotherapy agents [16]
but inducing apoptosis in liver cancer cell lines [31]. In
our study, Dkk3 expression alone did not increase basal
viability, suggesting that it plays a reactive role after apop-
tosis has begun. Interestingly, dkk3-deficient mice did not
display any phenotypes that would indicate defects in cell
survival or altered Wnt signaling [19]. Furthermore, these
mice had normal retinal development. If Dkk3 is protec-
tive only in response to retinal injury then tissue damage
may be required to reveal a phenotype. Alternatively,
Dkk3-mediated protection may be limited to specific cell
types in culture.
Müller glia secrete pro-survival growth factors during reti-
nal degeneration that are believed to rescue remaining
photoreceptors in a toxic environment [22,32-34]. We
recently demonstrated that Wnt signaling is upregulated
during retinal degeneration in Müller glia and Wnt activa-
tors protect primary photoreceptor cultures from apopto-
sis [25]. The localization of Dkk3 to Müller glia and its
increased expression during retinal degeneration, com-
bined with the functional properties identified above,
raise the intriguing possibility that Dkk3 may be a compo-
nent of Müller glia-mediated retinal protection. Such pro-
tection could occur directly by acting on vulnerable
photoreceptors, or indirectly by activating Wnt signaling.
The glia may secrete Dkk3 in vivo which could then
increase Wnt signaling in fellow glia or in neighboring cell
types. Although the cell lines are not an appropriate
model for photoreceptors, we have achieved our goal of
defining roles of Dkk3 in cultured cells as a first approach
towards determining the potential activity of Dkk3 in the
retina. Manipulating Dkk3 expression in normal and
degenerating retina will provide insight the role of Dkk3
in the retina.BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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Methods
Reagents
Dkk1 and Dkk3 expression vectors were generously pro-
vided by Dr. Niehrs (Heidelberg, Germany) [6]. The
HEK293, COS7, MIO-M1 cell lines and the primary
Müller glia cultures were maintained in DMEM growth
medium supplemented with 10% fetal bovine serum, 100
units/ml of penicillin and 100 μg/ml of streptomycin at
37°C in 5 % CO2. The Dkk3 stable cell line was estab-
lished by transfecting HEK293 cells with Dkk3 in the
pcDNA3 vector and selecting for clones using geneticin
[2]. The control "Vector" line was made in parallel by
transfecting with the empty vector. Transfections used
Lipofectamine (Invitrogen), electroporation or buffered
calcium phosphate, according to standard procedures.
Canonical Wnt signaling was induced by incubation with
conditioned media (CM) prepared from mouse L-cells
stably expressing Wnt3a (ATCC). The CM was filtered and
mixed 1:1 with normal media for use. Dkk3-containing
conditioned media was prepared from HEK293 cells sta-
bly expressing Dkk3. The control conditioned media for
Wnt3a was from parental L-cells and for Dkk3 it was from
the HEK293 "Vector" cell line. The following primary
antibodies were used: rabbit anti-glutamate synthetase
(Sigma, 1:500), Dkk3 polyclonal antibody (Santa Cruz,
1:100) and Dkk3 monoclonal antibody (R&D, 1:500).
Wnt activity assays
Cells were co-transfected with the Dkk plasmid, the TOP-
FLASH luciferase reporter plasmid (a generous gift from
Dr. R. Moon, University of Washington) and a LacZ-con-
taining plasmid. The endogenous β-catenin/Tcf transcrip-
tional complex binds to Tcf sequences upstream of the
enzyme luciferase in the TOP-FLASH plasmid vector, driv-
ing luciferase expression upon Wnt pathway activation.
The mutated FOP-FLASH plasmid was used as a control
and did not have luciferase activity in transfected cells
treated with Wnt3a (Figure 2A). Forty-eight hours after
transfection the cells were incubated with Wnt3a condi-
tioned media or control conditioned media for 16–24
hours and lysates were collected in Reporter lysis buffer
(Promega). Luciferase activity was measured in a Lumistar
Galaxy luminometer (BMG Labtech) and normalized to
β-galactosidase activity [2]. The assays were performed in
duplicate in at least five independent experiments. Values
were normalized to treatment with media not containing
Wnt3a.
Viability Assays
Caspase assays used the Ac-DEVD-AMC substrate (Alexis
Biochemicals) and were performed according to the man-
ufacturer's instructions. Briefly, approximately 5 × 105
cells were transfected in a 6-well plate and transfected. At
24 hours post-transfection apoptosis was induced by 1
μM staurosporine. The cells were lysed in RIPA buffer (50
mM Tris-HCl, pH 7.4, 1 % NP40, 0.25 % sodium deoxy-
cholate, 150 mM NaCl, 1 mM EDTA, 1 mM sodium
orthovanadate). 50 μL of DEVD-AMC reaction buffer mix-
ture containing 40 mM HEPES pH 7.5, 20% glycerol, 4
mM DTT and 0.2 mM of the fluorogenic caspase 3 sub-
strate Ac-DEVD-AMC was added to cellular lysates for 4
hour at 37°C, and fluorescence was then measured at 380
nm excitation and 450 nm emission. Fluorescent intensity
values were normalized to protein concentration, meas-
ured using the Lowry assay (BioRad).
Cell viability was measured using the XTT assay [35]. Cells
were seeded into 96-well plates and triplicate wells were
transfected with Dkk3, BclXL or LacZ. H2O2 was added for
24 hrs and then 10 μl WST-1 reagent (Roche) was added
for 1 hour and the release of formazan from mitochondria
was quantified at 450 nm using an ELISA plate reader.
Each experiment was performed at least three times on
different days with three to five replicates within an exper-
iment.
Primary Müller glia culture
All procedures involving animals were performed in
accordance with theARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Research and were
approved by the Animal Care and Use Committee at the
University of Miami Miller School of Medicine. Mouse
and rat Müller glia cultures were prepared from retinas
from animals from P4-P8. Retinas were dissociated with
papain and seeded onto cell culture plates. After 16 hr,
nonattached cells (mostly neuronal) were removed by
gentle agitation [25,36]. Immunohistochemistry using
antibodies against retinal cell-specific markers was used to
assess the purity of the culture, as described in [25]. One
hundred percent of the cells in the culture were identified
as Müller glia based on morphology and immunostaining
for the Müller glia marker glutamine synthetase (GS) and
the lack of immunodetection for other cell-specific
marker proteins. After one week in culture the cells were
trypsinized and equal numbers of cells were plated for
transfection using electroporation.
Immunohistochemistry
Eyes were enucleated from C57Bl/6 mice and immedi-
ately fixed in 4% paraformaldehyde, incubated in increas-
ing sucrose concentrations (5–20%), embedded in OCT
and flash-frozen. Sections (10 μm) were cut adjacent to
the optic nerve and placed onto Superfrost Plus slides. The
slides were blocked with goat serum, incubated with pri-
mary antibody overnight at 4°C, washed in phosphate-
buffered saline (PBS) then incubated with secondary anti-
body. The sections are counterstained with DAPI and
viewed using a fluorescent microscope (Zeiss Axiovert
200) and images were captured with a digital camera (Axi-BMC Cell Biology 2007, 8:52 http://www.biomedcentral.com/1471-2121/8/52
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ocam, Zeiss). Photographic and microscopic settings are
kept constant for comparisons between antibody and
control staining. Controls included tissue not incubated
with a primary antibody but otherwise treated identically.
For detection of Dkk3 in cultured cells, the cells were
grown on sterilized glass cover-slips and then immunos-
tained as above.
For the developmental series, immunohistochemistry was
performed essentially as previously described [37]. Mouse
retinas were fixed and embedded as above and twelve μm-
thick sections were cut. The slides were blocked with 20
mg/ml BSA and 2% donkey serum or 10% goat serum in
PBS, and then incubated overnight with goat anti-Dkk3
antiserum at 4°C. Sections were washed in PBS and incu-
bated with secondary antibodies conjugated to a fluoro-
chrome. The antibody selectivity was confirmed by
Western blotting whole retina lysates (Figure 2) and by
using HEK293 cells transiently expressing Dkk1, Dkk2
and Dkk3.
To immunostain primary Müller glia, cells grown on glass
cover-slips were fixed in 4 % paraformaldehyde, permea-
bilized with 0.05 % Triton-X100, and stained with anti-
bodies detecting Dkk3 (R&D) and glutamine synthetase
(Sigma) and the nuclei were counterstained with DAPI.
Western blot analysis
Eight adult wild-type retinas were pooled to prepare reti-
nal lysates for Western blotting. Retinas were homoge-
nized in RIPA buffer containing proteinase inhibitors,
centrifuged at maximum speed in a bench top centrifuge
and separated on a 12 % SDS-PAGE gel. To identify
secreted Dkk3 in media, MIO-M1 cells were grown to 80%
confluency, washed with PBS then incubated with serum-
free media overnight. The collected media was acetone
precipitated, centrifuged and resuspended in RIPA buffer
with proteinase inhibitors and then loaded onto an SDS-
PAGE gel. Dkk3 was detected using rat anti-Dkk3 mono-
clonal antibody (R&D), using chemiluminescence for
detection (Amersham Corp., Arlington Heights, IL).
Statistical Analysis
Values are reported in mean plus standard deviation.
Unpaired-t-test or one-way analysis of variance and Tukey
post-test were used for statistical analyses.
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